Ocugen OCGN
NASDAQ OCGN
$1.36 +0.01 (+0.74%)
At close: Sep 4, 2026 · 4:00 PM EDT

Ocugen (OCGN) Free Cash Flow (2014 - 2026)

Ocugen's (OCGN) quarterly Free Cash Flow came in at -$21.8 million in Q1 2026, down 12.53% YoY from -$24.9 million in Q1 2025, and down 54.31% on a QoQ basis from -$14.1 million in Q4 2025.

Analysis

Ocugen (OCGN) Free Cash Flow (2014 - 2026) Analysis & Trends

Ocugen (OCGN) has 13 years of Free Cash Flow data on file, last reported at -$21.8 million in Q1 2026.

  • Quarterly Free Cash Flow fell 12.53% year-over-year to -$21.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$59.6 million (down 14.67% YoY) and the FY2025 annual result came in at -$57.1 million, down 25.53% from the prior year.
  • Free Cash Flow slipped to -$21.8 million in Q1 2026, from -$14.1 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of -$5.7 million in Q4 2023 to a low of -$21.8 million in Q1 2026.
  • A 5-year average of -$14.7 million and a median of -$14.4 million in 2024 frame the typical range for Free Cash Flow.
  • Annual changes were most pronounced in 2022 — Free Cash Flow sank 175.78% — and 2023, when it soared 65.43%.
  • Tracing OCGN's Free Cash Flow over 5 years: stood at -$16.6 million in 2022, then soared by 65.43% to -$5.7 million in 2023, then tumbled by 80.88% to -$10.4 million in 2024, then sank by 36.14% to -$14.1 million in 2025, then sank by 54.31% to -$21.8 million in 2026.
  • The last three Free Cash Flow figures came in at -$21.8 million (Q1 2026), -$14.1 million (Q4 2025), and -$12.9 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.01 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 572.80 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -563.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -389.61 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 437.80 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 292.04 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 477.44 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -95.09 Mn
10 Ocugen 458.91 Mn 358.81 Mn - -12.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -12.22 Mn
Mar 31, 2026 -21.80 Mn
Dec 31, 2025 -14.00 Mn
Sep 30, 2025 -13.01 Mn
Jun 30, 2025 -10.77 Mn
Mar 31, 2025 -19.37 Mn
Dec 31, 2024 -10.38 Mn
Sep 30, 2024 -11.78 Mn
Jun 30, 2024 -10.42 Mn
Mar 31, 2024 -12.95 Mn
Dec 31, 2023 -14.02 Mn
Sep 30, 2023 -17.07 Mn
Jun 30, 2023 -21.58 Mn
Mar 31, 2023 -19.85 Mn
Dec 31, 2022 -18.94 Mn
Sep 30, 2022 -15.15 Mn
Jun 30, 2022 -14.78 Mn
Mar 31, 2022 -15.68 Mn
Dec 31, 2021 -13.00 Mn
Sep 30, 2021 -8.28 Mn